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Background: In the mouse, the patterns of DNA methylation are established during early embryonic development
in the epiblast. We quantified the targets and kinetics of DNA methylation acquisition in epiblast cells, and
determined the contribution of the de novo methyltransferases DNMT3A and DNMT3B to this process.
Results: We generated single-base maps of DNA methylation from the blastocyst to post-implantation stages and
in embryos lacking DNMT3A or DNMT3B activity. DNA methylation is established within two days of implantation
between embryonic days 4.5 and 6.5. The kinetics of de novo methylation are uniform throughout the genome,
suggesting a random mechanism of deposition. In contrast, many CpG islands acquire methylation slowly in late
epiblast cells. Five percent of CpG islands gain methylation and are found in the promoters of germline genes and
in exons of important developmental genes. The onset of global methylation correlates with the upregulation of
Dnmt3a/b genes in the early epiblast. DNMT3A and DNMT3B act redundantly to methylate the bulk genome and
repetitive elements, whereas DNMT3B has a prominent role in the methylation of CpG islands on autosomes and
the X chromosome. Reduced CpG island methylation in Dnmt3b-deficient embryos correlates with gene reactivation
in promoters but reduced transcript abundance in gene bodies. Finally, DNMT3B establishes secondary methylation
marks at imprinted loci, which distinguishes bona fide germline from somatic methylation imprints.
Conclusions: We reveal that the DNMT3 de novo methyltransferases play both redundant and specific functions in
the establishment of DNA methylation in the mouse embryo.Background
Methylation of cytosines is an epigenetic mark of DNA
with crucial functions in mammalian development and
diseases. In mammals, methylation occurs almost exclu-
sively in the context of cytosine-guanine (CpG) dinucleo-
tides, which are found at higher frequency in short regions
termed CpG islands (CGIs). Paradoxically, the majority of
CGIs remain unmethylated in all cell lineages [1-3]. The
contrast between the low methylation at CGIs and the
high methylation in CpG-poor sequences arises from the
accelerated mutational loss of methylated CpGs over evo-
lutionary time [2].
DNA methylation is reprogrammed during embryonic
development. The spermatozoa and oocyte acquire differ-
ential methylation at many sequences, which establishes a* Correspondence: michael.weber@unistra.fr
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unless otherwise stated.strong epigenetic asymmetry between the gametes that is
not limited to imprinted regions [4-6]. After fertilization,
these gametic profiles are globally erased to reach a low
point of methylation at the blastocyst stage [4-8]. Yet nu-
merous sequences maintain partial methylation in the
blastocysts, primarily on the oocyte-derived allele [4-8].
In the case of imprinted regions, this differential allelic
methylation is stably maintained throughout embryogen-
esis and adulthood at a small number of germline differ-
entially methylated regions (gDMRs). After implantation
of the embryo, DNA methylation is restored to high levels
in epiblast cells throughout the genome as well as at a
small number of CGIs [6-8].
Cytosine methylation is catalyzed by DNA methyltrans-
ferases (DNMTs). DNMT1 copies methylation on the new
DNA strand at hemimethylated CpG sites after DNA rep-
lication, which mediates epigenetic inheritance in dividing
cells. In contrast, DNMT3A and DNMT3B mediate deThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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CpGs. Another member of the family, DNMT3L, lacks
enzymatic activity but acts as a cofactor that stimulates
the activity of DNMT3A and DNMT3B in germ cells
[4,5]. The knockout of DNMT1 and DNMT3B in mice
leads to mid-gestation lethality, indicating that DNA
methylation is essential for development [9,10]. DNMT3A
knockout animals survive until birth but die at around
4 weeks of age [10].
Advances with high-throughput methods led to a better
characterization of the distribution of DNA methylation
in mouse embryos, yet several points remain to be clari-
fied, such as (i) the timing of acquisition of DNA methyla-
tion in embryos, (ii) the identity and role of CGIs that
gain methylation, and (iii) the contribution of DNMT3A
and DNMT3B to de novo methylation in the embryo. So
far the single-gene studies have indicated that DNMT3B
methylates the promoters of a few germline genes [7,11]
and protocadherin genes [12], whereas DNMT3A and
DNMT3B cooperate to methylate other sequences in the
mouse embryo [10,13,14]. This suggests that DNMT3A
and DNMT3B have both specific and overlapping func-
tions in embryonic methylation, which has not been inves-
tigated in a systematic way.
To answer these questions, we generated a single base
atlas of cytosine methylation by reduced representation bi-
sulfite sequencing (RRBS) throughout mouse embryonic
development starting from the blastocyst stage, as well as
in Dnmt3a and Dnmt3b mutant embryos. We show that
methylation is established rapidly at the time of implant-
ation by the combined action of DNMT3A and DNMT3B.
In contrast, CGIs behave as a functionally distinct class of
sequences that acquire methylation slowly mediated pri-
marily by DNMT3B. We provide a comprehensive ana-
lysis of the targets of CGI methylation in development
and studied their impact on gene expression in embryos.
Our study provides insights into the role and target speci-
ficities of the DNMT3 enzymes in mouse development.
Results
Temporal mapping of DNA methylation acquisition
during murine embryogenesis
To characterize the wave of de novo DNA methylation
in the mouse embryo, we generated single-base profiles
of cytosine methylation by RRBS at consecutive stages of
development between embryonic day (E)3.5 and E8.5
(Figure S1A,B in Additional file 1). We quantified methy-
lation for approximately 1,300,000 CpGs per sample
at an average sequencing depth of 68× (Figure S1A in
Additional file 1). As shown previously [4-7], the gen-
ome of E3.5 blastocysts is globally hypomethylated but
contains sequences with partial methylation caused by in-
complete erasure of gametic methylation (Figure 1A).
After E3.5, cytosine methylation progressively accumulatesafter implantation exclusively in a CG sequence context
(Figure S1C in Additional file 1). During this period, gene
bodies, transposable elements and CpG-poor promoters
are de novo methylated, whereas CpG-rich sequences are
protected from methylation (Figure 1B,C). ‘Canyons’, a
class of extended regions of low methylation that span loci
of developmental transcription factors [15], also form after
implantation through protection from de novo methyla-
tion (Figure 1C). Interestingly, most sequences with partial
methylation in blastocysts gain full methylation in post-
implantation embryos (Figure 1D); thus, resistance to
demethylation after fertilization predisposes to de novo
methylation in post-implantation embryos. We then in-
vestigated the dynamics of methylation by averaging
methylation in 400 bp tiles and searching for tiles that
gain or lose methylation at each developmental transition.
The most dramatic wave of de novo methylation occurs in
early epiblast between E4.5 and E5.5 (Figure 1E). In con-
trast there are very few demethylation events at any of the
developmental transitions (Figure 1E). This demonstrates
that de novo methylation occurs rapidly at the time of im-
plantation and is unidirectional. To precisely quantify the
kinetics of de novo methylation, we selected all tiles that
gain methylation in post-implantation embryos and plot-
ted their methylation as a function of the developmental
stage (Figure 1F). Methylation increases rapidly from
12% to 62% between E4.5 and E5.5, and reaches almost
maximum levels at E6.5 (Figure 1F). As a control, we show
that the imprinted gDMRs have stable methylation be-
tween 40 and 50% at all stages (Figure 1F). To ask if the
rate of de novo methylation varies along the genome, we
monitored methylation separately in exons, introns and
transposable elements and found that they acquire methy-
lation with similar kinetics (Figure 1G). We also moni-
tored methylation in classes of transposable elements and
found that, while they have varying degrees of methylation
in blastocysts, they all gain methylation with similar
kinetics in post-implantation embryos (Figure 1H). This
shows that de novo methylation occurs rapidly within two
days around implantation and is uniform throughout the
genome.
Kinetics of CpG island methylation in developing
embryos
Next we focused on CGIs. Out of the 16,023 UCSC CGIs,
89% are covered in each sample (Figure S1D in Additional
file 1) and 14,085 have methylation data in all samples.
Out of these 14,085 CGIs, 713 (5%) acquire more than
50% methylation in post-implantation embryos (Additional
file 2). Remarkably, the proportion of methylated CGIs
with more than 50% methylation is much lower at tran-
scription start sites (TSSs; 0.6%, 69/10,694 in total, 63/
10,422 on autosomes) than in intergenic and intragenic
regions, especially for CGIs covering exons (34%, 505/
Figure 1 Acquisition of CpG methylation occurs at implantation in mouse embryos. (A) Density histograms showing the distribution of
methylation levels measured at individual CpGs throughout embryonic development. Blast, blastocyst; Epb, epiblast; Emb, embryo. (B)
Distribution on CpG methylation in RefSeq genes and 10 kb of flanking sequences throughout embryonic development. For each protein-coding
RefSeq gene (excluding the X and Y chromosomes), we calculated methylation in 20 equal-sized windows within the gene and 10 1-kb windows
of flanking sequences. (C) Violin plots showing the acquisition of CpG methylation in post-implantation embryos compared with blastocysts in
various genome elements. TEs, transposable elements; HCPs, high CpG promoters; ICPs, intermediate CpG promoters; LCPs, low CpG promoters.
(D) Pairwise comparison of CpG methylation (measured in 400 bp tiles) in E3.5 blastocysts and E8.5 post-implantation embryos. The density of
points increases from blue to dark red. (E) Number of 400 bp tiles that gain or lose more than 20% CpG methylation at each developmental
transition. (F) Kinetics of de novo DNA methylation in development. We selected all the genomic tiles (400 bp) that gain methylation in post-implantation
embryos (defined as <20% methylation in E3.5 blastocysts and >50% methylation in E8.5 embryos) and then plotted their methylation as a function of the
developmental stage (black line). The red line shows the methylation for 17 imprinted germline DMRs. The lines represent the median methylation and
the error bars represent the 25th and 75th percentiles. (G) Kinetics of de novo DNA methylation in exons, introns and transposable elements (TEs).
(H) Kinetics of de novo DNA methylation in classes of transposable elements. LINE, long interspersed nuclear element; SINE, short interspersed
nuclear element. In (G,H), the lines depict the median methylation measured at each developmental stage.
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cause the UCSC annotations underestimate the number
of CGIs [16], we repeated this analysis with a less stringent
custom CGI annotation and found a similar repartition
of CGI methylation (Figure S2A,B in Additional file 1).
We explored the relationship between CGI methylationin pre- and post-implantation stages and found that half
of the CGIs methylated in post-implantation embryos
already have persistent gametic methylation in blasto-
cysts (Figure 2B). This reflects that CGIs that escape
complete demethylation before implantation are more likely
to reacquire methylation after implantation (Figure 2C).
Figure 2 Targets and kinetics of CpG island methylation in epiblast cells. (A) Distribution of E8.5 methylation scores in UCSC CGIs located in
promoters (-1,000 to 1,000 bp from RefSeq transcription start sites (TSSs)), exons, introns and intergenic sequences. X-linked CGIs are excluded
from this analysis. (B) Heatmap showing the methylation in gametes and blastocysts for all the CGIs methylated (>50%) in E8.5 embryos. Approximately
half of the CGIs inherit partial methylation from the oocyte. (C) Percentage of CGIs that gain >50% methylation in E8.5 embryos depending on their
methylation in blastocysts. CGIs with oocyte-derived methylation in blastocysts have a much higher probability to gain methylation in post-implantation
embryos. (D) Kinetics of de novo methylation in CGIs compared with the genome (measured in 400 bp genomic tiles). The graph depicts de novo
methylated sequences defined as <20% methylation in E3.5 blastocysts and >50% methylation in E8.5 embryos. (E) Kinetics of de novo
methylation for CGIs in TSSs, exons, introns and intergenic sequences (selected as <20% methylation in E3.5 blastocysts and >50% methylation in
E8.5 embryos) compared with the whole genome (black line). The lines depict the median methylation at each stage. (F) Examples of single-CpG RRBS
profiles at CGIs with delayed DNA methylation in the promoter of Sycp3 and one exon of Blc11b (chr12:107,915,284-107,917,294). Here and in
other figures, the green bars depict the position of the CGI. In comparison, the CpG-poor promoter of the Slc6a19 gene gains methylation
between E4.5 and E5.5. (G) Gene Ontology terms associated with methylated CGIs (>50% methylation in E8.5 embryos) in TSSs and exons.
(H) Distribution of methylation in adult tissues [3] for CGIs with >50% methylation in E8.5 embryos.
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blastocysts rarely translates into lifelong imprinted methy-
lation [7,17]. We then monitored the kinetics of de novo
methylation at CGIs and found that they acquire methy-
lation at a slower rate compared with the bulk genome
(Figure 2D). A similar delay in methylation is observed
when we use our extended set of custom annotated CGIs
(Figure S2C in Additional file 1). This delay is most evi-
dent at TSS-proximal CGIs (Figure 2E), as illustrated by
the Sycp3 promoter (Figure 2F) and several other pro-
moters (Figure S3A in Additional file 1). Methylation of
intergenic and intragenic CGIs is, on average, less delayed
than at promoters (Figure 2E); nevertheless, many of these
CGIs also gain delayed methylation as exemplified by
intragenic CGIs in the Bcl11b, Dact1 and Cux1 genes
(Figure 2F; Figure S3B in Additional file 1).
CpG island methylation is recruited to important
developmental genes
To gain insights into the function of CGI methylation,
we performed ontology analyses on genes that gain CGI
methylation after implantation. In accordance with pre-
vious data [7,11], promoter CGI methylation is enriched
at genes involved in gamete functions (Figure 2G; Figure
S4A in Additional file 1). Using our custom CGI annota-
tion, we identified 87 CGI promoters with more than
50% methylation in E8.5 embryos and found that 79%
(69/87) are associated with germline genes (Additional
file 3). The targets identified here and in previous studies
[7] reveal that promoter CGI methylation is recruited in
particular to genes involved in gamete chromatin (Brdt,
H1fnt, Hist1h2aa/ba, H2afy3), meiosis (Spo11, Sycp1/2/3,
Syce1/3, Msh4, Hormad1/2) and the Piwi-interacting RNA
(piRNA) pathway (Piwil1/2/4, Mov10l1, Fkbp6, Mael,
Tdrd1/9/12, Rnf17, Ddx4, Asz1). In contrast, exon CGI
methylation is targeted to genes with important develop-
mental functions in the regulation of transcription, mor-
phogenesis, signaling pathways and neuronal development
(Figure 2G). As examples, key transcription factor genes
(Cux1, Bcl11b, Klf3, Daxx, Foxo3, Zfp64) gain exon CGI
methylation in the epiblast, as well as several genes of the
Wnt/β-catenin signaling pathway that plays pivotal roles
in embryogenesis and gastrulation. In contrast, we found
no ontology category associated with intron CGI methyla-
tion (data not shown). To investigate if intragenic CGI
methylation correlates with transcription of the surround-
ing gene as is the case in oocytes [4,18], we compared
CGI methylation with RNA-Seq in E8.5 embryos and
found a tendency for methylated CGIs in exons, but not
introns, to be located within active transcription units
(Figure S4B in Additional file 1). To ask if CGI methyla-
tion persists in the adult, we interrogated a published
dataset from mouse adult tissues [3] and found that CGIs
in promoters, exons, introns or intergenic regions remainhighly methylated in all tissues (Figure 2H). Thus, CGI
methylation in the epiblast is targeted to important devel-
opmental genes and constitutes a stable epigenetic signa-
ture of all somatic lineages.
A class of CpG islands gains partial methylation in
somatic lineages
We noted that CGIs have a peculiar distribution of CpG
methylation in post-implantation embryos characterized by
a high prevalence of intermediate methylation (Figure 3A).
We defined partially methylated CGIs (pmCGIs) as having
methylation of between 15 and 60% in E8.5 embryos
(excluding the known imprinted differentially methyl-
ated regions (DMRs) and the X chromosome). The
pmCGIs are found within and outside genes but their
relative frequency is the highest in TSSs (Figure 3B,C).
Interestingly their CpG ratio is intermediate between
those of methylated and unmethylated CGIs (Figure 3D).
To investigate the possibility that the pmCGIs gain methy-
lation at later stages of development, we generated RRBS
methylomes in E10.5 embryos and adult liver, and in-
vestigated methylomes from adult tissues [3]. Most pro-
moter pmCGIs retain partial methylation throughout
development and in adult tissues (Figure 3E,F). Similarly,
a high proportion of intergenic and intragenic pmCGI
harbors partial methylation in all tissues while some occa-
sionally are fully methylated in some tissues (data not
shown). We then asked if this partial methylation repre-
sents an allele-specific methylation or a low methyla-
tion per allele. To this end we extracted single-allele
methylation data from the sequencing reads and found
that, in contrast to the allele-specific methylation of
imprinted gDMRs, the partial methylation at pmCGIs
results from a low density of methylated cytosines per
allele (Figure 3G). This is confirmed by bisulfite cloning
and sequencing of larger amplicons (400 to 500 bp) in
four pmCGI promoters in adult liver (Additional file 1).
Interestingly, whole-genome bisulfite sequencing and the
bisulfite cloning reveal that pmCGIs contain patches of
low and high susceptibility to methylation (Additional
file 1), which could reflect differential susceptibility caused
by the positioning of nucleosomes. To further characterize
the promoter pmCGIs, we performed an ontology ana-
lysis and found that, similar to the fully methylated
CGI promoters, they are enriched for germline-specific
genes (Figure 3H). Using our custom annotation pipe-
line, we identified 50 high confidence pmCGI pro-
moters and counted that 60% (30/50) are linked to
germline genes (Additional file 3). Representative ex-
amples include Smc1b, Papolb, Boll, Mei1, Rbmxl2
and Rbm46 (Figure 3F). This identifies a novel class
of methylated promoter CGIs and extends the reper-
toire of germline genes targeted by DNA methylation
in embryogenesis.
Figure 3 A class of CpG islands gains partial methylation during development. (A) Density histograms showing the distribution of methylation
in E8.5 embryos in genomic tiles (400 bp) covering CpG-poor regions and CGIs, which reveals a high prevalence of partially methylated CGIs (pmCGIs).
(B) Frequency of pmCGIs in CGIs covering TSSs and exons. (C) Distribution of pmCGIs in TSSs, exons, introns and intergenic regions. (D) Comparison
of the distribution of CpG ratios in unmethylated (u; <10% methylation in E8.5 embryos), partially methylated (pm; >15% and <60% methylation) and
methylated (m; >60% methylation) CGIs. (E) Dynamics of DNA methylation at TSS-proximal pmCGIs (defined as >15% and <60% methylation in E8.5
embryos) across embryonic development and in adult tissues. Crb, cerebellum; Pancr, pancreas. (F) Examples of RRBS methylation scores at three
TSS-associated pmCGIs in blastocysts (E3.5), post-implantation embryos (E8.5 and E10.5) and adult liver. (G) Distribution of RRBS single-allele
methylation scores from E8.5 embryos in TSS-proximal pmCGIs compared with imprinted gDMRs. (H) Gene Ontology terms associated
with TSS-proximal pmCGIs.
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genome
Next we investigated the contribution of the de novo en-
zymes DNMT3A and DNMT3B to methylation in em-
bryos. We first followed the expression of Dnmt3a/b
mRNAs by quantitative RT-PCR (RT-qPCR) and found
that both genes are upregulated in early epiblast cells,
which coincides with the onset of genome-wide methyla-
tion (Figure 4A). Notably, Dnmt3b mRNAs reach higher
levels of expression than Dnmt3a (Figure 4A). RNA-Seq
indicates that embryos express predominantly the short
Dnmt3a2 isoform and the full length Dnmt3b1 isoform
(Figure S6A in Additional file 1). We generated embryos
homozygous for catalytically inactive alleles of Dnmt3a
and Dnmt3b (referred to as Dnmt3a-/- and Dnmt3b-/-)
and performed RRBS at the E8.5 stage, which led to
highly reproducible data in independent embryos (Figure
S1E in Additional file 1). Importantly, we verified thatthe inactivation of one Dnmt3 gene does not modify the
expression of the other Dnmt genes in embryos (Figure
S6B,C in Additional file 1). We found that the inactiva-
tion of Dnmt3a or Dnmt3b leads to a partial reduction
in global methylation, indicating that the inactivation of
one enzyme is compensated for by the other and that
both enzymes cooperate to methylate the bulk genome
(Figure 4B,C). The decrease in methylation is unidirec-
tional with no signs of gain of methylation, confirming
that these enzymes solely act as methylases (Figure 4D).
Overall, the inactivation of Dnmt3b leads to a higher
number of hypomethylated sequences and an increased
amplitude in the loss of methylation compared with
Dnmt3a (Figure 4E). Detailed quantification is given
in Figure 4F and shows that the median methylation of
methylated sequences in E8.5 embryos drops from 91% in
wild type (WT) to 86% in Dnmt3a-/- and 72% in Dnmt3b-/-
embryos. These variations are equally distributed in exons,
Figure 4 Methylome profiling in DNMT3A and DNMT3B-deficient embryos. (A) mRNA expression of Dnmt3a/b genes in embryos. Expression
was measured by RT-qPCR on 5 to 10 pooled embryos and is depicted as a ratio relative to the expression of two housekeeping genes (Actb
and Rpl13a). The primers used for RT-qPCR were designed in the last exons to amplify all isoforms. Blast, blastocyst; Epb, epiblast; Emb,
embryo. (B) Pairwise comparison of CpG methylation in 400 bp tiles in wild-type (WT) compared with Dnmt3a-/- and Dnmt3b-/- E8.5 embryos.
(C) Distribution of CpG methylation in RefSeq genes and 10 kb of flanking sequences in WT, Dnmt3a-/- or Dnmt3b-/- E8.5 embryos. (D) Number of
400 bp tiles that lose or gain more than 10% methylation in Dnmt3a-/- and Dnmt3b-/- compared with WT E8.5 embryos. (E) Detailed representation
of the extent of methylation loss detected in 400 bp tiles in Dnmt3a-/- and Dnmt3b-/- compared with WT E8.5 embryos. (F) Boxplot representing the
distribution of CpG methylation in the whole genome (400 bp tiles), exons, introns and transposable elements (TEs) in WT, Dnmt3a-/- and Dnmt3b-/-
E8.5 embryos. Only sequences with >50% methylation in WT E8.5 embryos are considered. (G) Distribution of CpG methylation in several families of
transposable elements in WT, Dnmt3a-/- and Dnmt3b-/- E8.5 embryos. IAP, intracisternal A-particle; LINE, long interspersed nuclear element; SINE, short
interspersed nuclear element.
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monitored methylation of various classes of transposable
elements (long interspersed nuclear elements (LINEs),
short interspersed nuclear element (SINEs), long terminal
repeats) and found that they follow the same trend with
a small decrease in methylation (approximately 5%) in
Dnmt3a-/- embryos and a more pronounced decrease
(approximately 20%) in Dnmt3b-/- embryos (Figure 4G).
The exception is intracisternal A-particle elements, which
are marginally affected in Dnmt3a-/- and Dnmt3b-/- em-
bryos, which is consistent with previous data [10,14]
and reflects that intracisternal A-particles maintain high
methylation in pre-implantation stages. We conclude that
DNMT3A and DNMT3B cooperate to establish DNAmethylation in embryos, with DNMT3B having a greater
contribution than DNMT3A.
CpG islands are preferentially methylated by DNMT3B
We next investigated if DNMT3A and DNMT3B have
specific targets. As shown in Figure 4E, we identified se-
verely hypomethylated sequences in Dnmt3b-/- but not
Dnmt3a-/- embryos, indicating that only DNMT3B
has specific targets for methylation. We identified 1,759
Dnmt3b-dependent targets defined as losing more than
60% methylation in Dnmt3b-/- compared with WT em-
bryos (Additional file 4). These targets are distributed in
promoters, gene bodies and intergenic regions (Figure S7A
in Additional file 1) and have an increased CpG density
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role for DNMT3B at CGIs. To verify this hypothesis, we
monitored methylation at CGIs and found that they are
more severely demethylated in Dnmt3b-/- embryos com-
pared with the bulk genome (Figure 5A). Many CGIs are
markedly hypomethylated in Dnmt3b-/- compared with
WT embryos, such as in the promoters of Sycp3, Dmrtb1,
Mael, and gene bodies of Cux1 and Bcl11b (Figure 5B).
Remarkably, the DNMT3B-dependent CGIs overlap with
the ones that acquire delayed methylation in late epiblast
cells (for example, Sycp3 and Bcl11b in Figures 2F and 5B).
We investigated this observation on a global scale and
confirmed that the methylation of the ‘slow’ CGIs returns
to levels close to those of blastocysts in Dnmt3b-/- E8.5
embryos (Figure 5C, left panel). In contrast the methy-
lation of the ‘fast’ CGIs is less affected by the inacti-
vation of DNMT3B and can be partly compensated
for by DNMT3A (Figure 5C, right panel). The methy-
lation of the pmCGIs, which can be viewed as extreme
cases of ‘slow’ CGIs, also strictly depends on DNMT3B
activity (Figure 5D). Lastly, we show that the DNMT3B-
dependent targets identified in E8.5 embryos are hypo-
methylated to a similar extent in limbs from E11.5
Dnmt3b-/- embryos (Figure S7C in Additional file 1),
demonstrating that DNMT3A is incapable of compensat-
ing DNMT3B at these targets even over a prolonged
period of development. Altogether this reveals a specificFigure 5 DNMT3B methylates CpG islands in epiblast cells. (A) Boxplo
(400 bp tiles) and CGIs in WT, Dnmt3a-/- and Dnmt3b-/- E8.5 embryos. Only se
(B) Representative examples of RRBS profiles at DNMT3B-dependent CGIs in W
Dmrtb1, Mael) and gene bodies (Cux1, chr5:136,274,862-136,275,397; Bcl11b, ch
embryonic development and in Dnmt3-mutant E8.5 embryos in slow (<20% m
methylation in E3.5, >50% methylation in E5.5 and >50% methylation in E8.5)
in E8.5 embryos at the Rbm46 CGI. The box plot shows the distribution of me
Dnmt3-mutant E8.5 embryos.role for DNMT3B in the methylation of CpG-rich DNA
in epiblast cells.
Influence of DNMT3B-dependent methylation on gene
expression in embryos
To explore the influence of DNMT3B-dependent methy-
lation on gene transcription, we conducted RNA-Seq in
three WT and Dnmt3b-/- E8.5 embryos (Figure S6D in
Additional file 1). Overall we found relatively similar
transcriptome profiles (Figure 6A). We identified 306
upregulated and 528 downregulated genes in Dnmt3b-/-
compared with WT embryos, but genes with the highest
fold change are mostly upregulated (Figure 6A; Additional
file 5). The reduction of promoter CGI methylation in
Dnmt3b-/- embryos strongly correlates with gene upregu-
lation (Figure 6B), which leads to the ectopic activation of
many full length germline transcripts that constitute 81%
of the genes upregulated more than five-fold in Dnmt3b-/-
embryos (Figure 6C; Figure S8A,B in Additional file 1).
The only other genes strongly upregulated in Dnm3b-/-
embryos are genes of the Rhox cluster (Gm9, Rhox4g,
Rhox4e, Rhox9) [14] and members of a family of X-linked
imprinted genes (Xlr3a/b/c, Xlr4a/b/c) (Figure S8A in
Additional file 1; Additional file 5). Thus, DNMT3B re-
presses a small number of genes mainly associated with
germline function. We validated the potent upregulation
of germline genes by RT-qPCR in E8.5 Dnmt3b-/-t showing the distribution of CpG methylation in the whole genome
quences with >50% methylation in WT E8.5 embryos are considered.
T, Dnmt3a-/- and Dnmt3b-/- E8.5 embryos in gene promoters (Sycp3,
r12:107,915,284-107,917,294). (C) Dynamics of DNA methylation across
ethylation in E3.5, <50% in E5.5 and >50% in E8.5) and fast (<20%
CGIs. (D) DNMT3B methylates pmCGIs, as illustrated by the RRBS profiles
thylation at all pmCGIs in blastocysts (E3.5), WT E8.5 embryos and
Figure 6 Transcriptome of Dnmt3b-/- embryos. (A) Scatter plot of normalized read counts per gene (average of three replicates) calculated by
DESeq2 in WT and Dnmt3b-/- E8.5 embryos. The red dots represent the genes called differentially expressed with a false discovery rate-adjusted
P-value <0.05 and fold change >2. The numbers of genes upregulated and downregulated are indicated. (B) Consequences of reduced CGI
methylation on gene expression. The boxplot shows Fragments Per Kilobase of exon per Million fragments mapped (FPKM) scores for genes with
reduced methylation (>50% decrease of methylation in Dnmt3b-/- compared with WT embryos) of a CGI covering a TSS, exon or intron, as well
as genes with a pmCGI in the TSS. **P < 0.01, ***P < 0.001 (Wilcoxon test). (C) RNA-Seq read coverage at the germline-specific gene Mael in three
WT and Dnmt3b-/- embryos. (D) RT-qPCR validation of the upregulation of germline genes in Dnmt3b-/- E8.5 embryos. The heatmap on the left
depicts the extent of TSS CGI hypomethylation in Dnmt3b-/- embryos. Gene expression is depicted in the bar graphs as a ratio relative to the
expression of two housekeeping genes (Actb and Rpl13a). The error bars represent mean deviations from measurements in independent embryos
(n = 3). As a control we show the expression of Dnmt3b measured with primers that amplify within the Cre-deleted catalytic exons.
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(Figure 6D; Figure S8C in Additional file 1), demonstrat-
ing that CGI methylation establishes long-term silencing
of germline promoters throughout development. Inter-
estingly, the absence of partial methylation at pmCGI
promoters is also associated with a minor increase of
transcript abundance in Dnmt3b-/- embryos (Figure 6B),
which was verified by RT-qPCR at three germline pmCGI
genes (Figure S8C in Additional file 1). Thus, partial pro-
moter methylation has a small contribution to promoter
silencing at some genes. Consistent with a contribution
of DNA methylation to the silencing of pluripotency
genes in development [19], reduced promoter methyla-
tion is associated with a modest increase in transcript
abundance of several pluripotency genes in Dnmt3b-/-
embryos, in particular Dppa3/Stella and Dppa4 (Figure
S8D in Additional file 1). Finally, we investigated the in-
fluence of intragenic CGI methylation on transcript abun-
dance. Interestingly, RNA-Seq indicates that genes with
reduced CGI methylation over an exon are significantly
downregulated in Dnmt3b-/- embryos (Figure 6B), consistentwith a role of intragenic CGI methylation in influencing
the expression of the surrounding gene [20]. Overall, this
shows that DNMT3B-dependent CGI methylation has a
repressive function at promoters and a putative positive
influence on transcript abundance in the body of genes.
DNMT3 knockouts distinguish germline from somatic
imprinted differentially methylated regions
It has been suggested that the DNMT3 enzymes partici-
pate in the maintenance of DNA methylation in mamma-
lian cells [21]. To ask if DNMT3A/B contribute to the
maintenance of DNA methylation imprints, we monitored
methylation at 17 imprinted gDMRs and found no signs
of hypomethylation in Dnmt3a-/- or Dnmt3b-/- embryos
(Figure 7A; Figure S9A in Additional file 1). This agrees
with previous results obtained at the Igf2r gDMR [14] and
two paternal gDMRs [22], and indicates that the individual
DNMT3 enzymes are dispensable for the maintenance of
methylation imprints in vivo. The possibility remains that
DNMT3A/B are redundant for the maintenance of DNA
methylation, which needs to be tested in double mutants.
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acquire allele-specific DNA methylation after implant-
ation. We profiled DNA methylation at several known
sDMRs and observed that, in accordance with published
data [23,24], they acquire methylation with variable kinet-
ics in development (Figure 7B). Interestingly, these sDMRs
all acquire methylation in a DNMT3B-dependent manner
(Figure 7B). Accordingly, this is associated with a less than
two-fold increase of some of these imprinted transcripts
(H19, Meg3, Cdkn1c, Mkrn3) in Dnmt3b-/- embryos
(Figure S8E in Additional file 1). We then reasoned that
our data can serve to accurately distinguish gDMRs from
sDMRs: gDMRs are stable throughout embryogenesis
and unaffected in Dnmt3 mutants, whereas sDMRs
gain DNMT3B-dependent methylation after implantation.
Using these criteria, we reassessed the known gDMRs and
confirmed that they inherit stable gametic methylation ex-
cept for the Exon1A gDMR at the Gnas locus. The Gnas
locus is unusual as previous studies identified two gDMRs
in the GnasXL promoter and Exon1A (Figure 7C) [25,26].
We now reveal that the Exon1A DMR is a sDMR: itFigure 7 Role of DNMT3B at imprinted differentially methylated regio
the methylation of 17 imprinted germline DMRs in WT, Dnmt3a-/- and Dnmt3
and in Dnmt3 knockout E8.5 embryos at somatic DMRs: Cdkn1c (chr7:1
Meg3 (chr12:109,540,809-109,541,073), H19 (chr7:142,578,145-142,578,462
throughout development and in Dnmt3 knockout E8.5 embryos at the three
position of the DMRs are shown on top of the graph. The detailed RRBS pr
of RRBS profiles at CGI promoters of three X-inactivated genes in fema
of the global distribution of CGI methylation in autosomes (left) and on
embryos and female adult liver.inefficiently maintains maternal methylation in blastocysts
and undergoes DNMT3B-dependent de novo methylation
after implantation (Figure 7C; Figure S9B in Additional
file 1). This suggests a revised model of imprinting at the
Gnas locus under the control of only one gDMR.
DNMT3B methylates CpG islands on the inactive X
chromosome in females
CGIs gain DNA methylation on the inactive copy of the
X chromosome in female XX embryos to stabilize X-
inactivation. To explore the role of DNMT3 enzymes in
X-linked CGI methylation, we examined RRBS methy-
lomes in female embryos. A visual inspection at pro-
moters of X-inactivated genes shows that they acquire
partial CGI methylation in female but not male E8.5 em-
bryos (Figure 7D). We investigated this in a systematic
way and found that all the CGIs on the X chromosome
show a concordant gain of methylation in female em-
bryos (Figure 7E). The methylation in female E8.5 em-
bryos is only slightly lower than the one observed in a
female adult liver (Figure 7E), indicating that most of thens and X-linked CpG islands in embryos. (A) Box-plot representing
b-/- E8.5 embryos. (B) Dynamics of methylation throughout development
43,459,734-143,460,383), Slc22a18 (chr7:143,465,018-143,465,543),
) and Mkrn3 (chr7:62,419,498-62,420,497). (C) Dynamics of methylation
DMRs of the Gnas locus. The genomic organization of the locus and the
ofiles are shown in Figure S9B in Additional file 1. (D) Examples
le WT and Dnmt3-mutant embryos at the E8.5 stage. (E) Box plots
the X chromosome (right) in WT E8.5 embryos, female Dnmt3-mutant
Auclair et al. Genome Biology  (2014) 15:545 Page 11 of 16X-linked CGI methylation is already established in early
post-implantation embryos. In accordance with human
data [27], we found that X-linked CGI methylation is not
restricted to promoters but occurs at all CGIs in pro-
moters, gene bodies and intergenic regions (Figure S10A
in Additional file 1). In contrast, CGI methylation is
not found at some of the genes known to escape X-
inactivation in the mouse (Figure S10B in Additional
file 1). Out of 13 described escapee genes in the mouse
[28], 10 have their promoter covered in our dataset and 5
show no signs of promoter methylation (Figure S10C
in Additional file 1). The other five genes might be mis-
annotated escapees or could have alternative promoters.
We then investigated the contribution of DNMT3 en-
zymes to X-linked methylation by examining RRBS
methylomes generated in Dnmt3a-/- and Dnmt3b-/-
female E8.5 embryos. Strikingly, X-linked CGI methylation
is unaffected in Dnmt3a-/- embryos but completely absent
in Dnmt3b-/- embryos (Figure 7D,E). DNMT3B methyl-
ates all the CGIs of the inactive X chromosome in pro-
moters but also intragenic and intergenic regions (Figure
S10A in Additional file 1). These data extend results ob-
tained on candidate X-linked CGIs [29,30] and demon-
strate that DNMT3B catalyzes methylation of all CGIs on
the inactive X chromosome in female embryos.
Discussion
Using quantitative profiling of cytosine methylation at
single-base resolution, we determined the kinetics of
DNA methylation and the specificity of the de novo
DNMT3 enzymes in mouse embryos in vivo. This ex-
tends previous findings on the dynamics of DNA methy-
lation in mouse embryogenesis [4-8]. Our data provide a
useful resource for investigating the inheritance and re-
programming of DNA methylation in embryos, notably
by accurately distinguishing gDMRs from sDMRs at
imprinted loci. We reassessed all the known gDMRs at
imprinted loci and confirmed that they inherit gametic
DNA methylation with no contribution of de novo methy-
lation after fertilization. The exception is the Exon1A
DMR at the Gnas locus, which was previously identified
as a gDMR that maintains maternal methylation in blasto-
cysts and post-implantation embryos [25]. Another gDMR
was described in the GnasXL promoter, which made the
Gnas locus an unusual case of imprinted loci with two
gDMRs. We now reveal that the Exon1A DMR is only
partially resistant to methylation reprogramming in blas-
tocysts and gains DNMT3B-dependent methylation after
implantation, which classifies it as a sDMR. This sug-
gests a revised model of imprinting at the Gnas locus
under the control of only one gDMR covering the GnasXL
promoter, which then controls the establishment of
the sDMRs in cis. In accordance with this model, the
deletion of the GnasXL DMR influences methylationof the Exon1A DMR in embryos, whereas the opposite is
not true [26,31,32].
We show that the embryo acquires global DNA methy-
lation within a short period of time between 4.5 and
6.5 days post coitum in epiblast cells. This is faster than
when it is recapitulated in vitro in embryonic stem (ES)
cells switched from 2i to serum conditions. In this case,
bisulfite sequencing profiling revealed that global methyla-
tion is completed only 5 to 7 days after adapting ES cells
from 2i to serum [33]. These differences could be due to
different levels of expression of the DNMTs. One import-
ant question is whether de novo methylation occurs by
default or is triggered by pre-existing factors to spe-
cific sites in the genome. Our kinetic study supports
the default model of methylation because (1) methylation
increases with similar kinetics throughout the genome,
and (2) methylation increases rapidly as soon as DNMT3
genes are upregulated in early epiblast cells. As we studied
whole populations of cells, however, we cannot exclude
the existence of cell-to-cell heterogeneity in the kinetics of
acquisition. This hints at a random mechanism of depos-
ition of methylation rather than initiation and spreading
from defined methylation centers, as has also been ob-
served in ES cells switched from 2i to serum [33]. This
model is consistent with studies showing that DNMT3 en-
zymes are recruited by default to chromatin via their
PWWP domain [34-36].
Our results highlight the distinct regulation of DNA
methylation at CGIs compared with the bulk genome:
CGIs are mostly resistant to methylation at implantation,
acquire delayed methylation in late epiblast cells, and fre-
quently acquire partial methylation. Only 5% (713/14,085)
of the annotated UCSC CGIs gain more than 50%
methylation in the post-implantation embryo. The rar-
ity of methylation at CGIs suggests that they are intrin-
sically protected from default methylation at the time
of implantation. This could be mediated by proteins with
CXXC domains that recognize stretches of CpG-rich
DNA and could impose a chromatin structure that makes
DNA refractory to methylation. The methylation-free state
of CGIs could also be related to their activity as platforms
for the binding of transcription factors. In line with this
idea, mutations in transcription factor binding sites can
relieve the protection from methylation at CGIs [37,38].
This model would predict that all CGIs are transcription-
ally active or at least bound by the transcription machin-
ery in embryos at the time of de novo methylation. An
alternative possibility is that CGIs are ‘methylatable’ but
that methylation is constantly removed via demethylation.
The maintenance of the hypomethylated state of CGIs by
demethylation could involve the action of TDG (thymine
DNA glycosylase) or TET (ten-eleven translocation) pro-
teins. Indeed, the inactivation of TDG in the mouse or the
combined deficiency of TET1/2/3 in mouse ES cells leads
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opmental potential [39-41]. In this context, the methyla-
tion of a subset of CGIs probably requires specific
molecular pathways necessary to override the intrinsic
resistance to methylation before allowing the deposition
of DNA methylation. This would explain that CGI methy-
lation is delayed compared with the bulk genome and can
be partial due to inefficient targeting. To date very little is
known about these molecular mechanisms that recruit
DNA methylation to a subset of CGIs. Existing evidence
indicates that it could involve non-coding RNAs [42] or
DNA-binding repressors such as E2F6 [43].
Interestingly, intragenic and intergenic CGIs are much
more prone to developmental DNA methylation than in
the TSS. This was observed previously in differentiated lin-
eages and suggests important roles for intragenic methyla-
tion in gene regulation [16,44,45]. In line with this idea,
we show that intragenic CGI methylation is recruited to
genes with important developmental functions in embry-
onic morphogenesis, signaling pathways and transcription
regulation. In addition, our RNA-Seq data show that re-
duced intragenic CGI methylation in Dnmt3b-/- embryos
is associated with small changes in transcript abundance
of the surrounding genes, suggesting that intragenic CGI
methylation plays a role in the fine tuning of expression of
developmental genes in the embryo. A positive correlation
between intragenic DNA methylation and gene expression
has been documented previously in normal and malignant
mammalian cells (reviewed in [20]). Functionally, it can be
speculated that intragenic methylation facilitates the tran-
scription elongation or influences the posttranscriptional
processing of the surrounding mRNA. Another possibility
is that DNA methylation regulates the activity of alterna-
tive intragenic CGI promoters or promoters of regulatory
non-coding RNAs. However, we found so far little evi-
dence in the RNA-Seq data for activated transcription in
the sense or antisense orientation at demethylated intra-
genic CGIs in Dnmt3b-/- embryos (data not shown).
Hence additional investigations are needed to explore the
possible functional impact of intragenic CGI methylation
in gene regulation [20]. In the TSS, CGI methylation is ex-
tremely rare (less than 1% have more than 20% methyla-
tion) and occurs almost exclusively at the promoters of
germline-specific genes. This remarkable specificity, to-
gether with the fact that germline genes are durably reacti-
vated in methylation-deficient embryos and cultured cells
as shown by us and others [11,46-48], indicates that the si-
lencing of the germline program in soma is a major evolu-
tionary function of DNA methylation in mammals.
Mammalian genomes encode two de novo methyltrans-
ferases (DNMT3A and DNMT3B) but their respective
contribution to embryonic methylation remained poorly
characterized. We generated methylomes in embryos with
catalytically inactive mutants of Dnmt3a or Dnmt3band found that, in agreement with data at candidate loci
[7,10,14,29,43], DNMT3A and DNMT3B have both re-
dundant and specific functions. First, we show that the
inactivation of Dnmt3a or Dnmt3b induces a partial
hypomethylation of the genome. The sum of the methyla-
tion in the knockout embryos is much higher than the
methylation in WT embryos, indicating that the catalytic
activities of both enzymes can compensate for each other
and cooperate to methylate the genome. We note, how-
ever, that DNMT3B makes a greater contribution than
DNMT3A, probably because of the higher expression of
Dnmt3b compared with Dnmt3a in epiblasts as observed
here by RT-qPCR (Figure 4A) and previously by immuno-
staining [10,49]. Their redundant function might have
evolved to ensure robust and efficient methylation in
embryos. Despite the global redundancy, DNMT3B
also has a specific role in the methylation of many CGIs
on autosomes and the inactive X chromosome that are
dramatically hypomethylated in Dnmt3b-/- embryos. This
highlights again that DNA methylation at CGIs is con-
trolled by different molecular pathways compared with
the bulk genome, which involve the preferential recruit-
ment of DNMT3B. Our data contribute to explain the
more severe phenotype of Dnmt3b-/- compared with
Dnmt3a-/- mice [10]. DNMT3B makes a greater contribu-
tion to genome methylation and specifically methylates a
set of CpG-dense sequences associated with developmen-
tal and imprinted genes, which leads to the deregulation
of germline, pluripotency and imprinted genes and hun-
dreds of other direct or indirect targets in Dnmt3b-defi-
cient embryos. Which of these genes contribute the most
to the embryonic lethality of Dnmt3b-/- animals remains
to be investigated. The preferential role of DNMT3B at
CGIs is compatible with data showing that mice or hu-
man ICF syndrome (immunodeficiency, centromeric
instability, facial anomalies) patients with DNMT3B mu-
tations have reduced methylation at CGIs on autosomes
and the inactive X chromosome [43,50,51], suggesting a
functional conservation of DNMT3B function between
mice and humans. Our findings also shed new light on the
possible molecular dysfunctions caused by the mutations
of DNMT3B in the human ICF syndrome and might help
to identify new epigenetically deregulated targets for diag-
nosis [52].
Conclusions
We revealed the target specificities of the de novo meth-
yltransferases DNMT3A and DNMT3B in mouse develop-
ment in vivo. We show that they have redundant catalytic
functions in global genome methylation at implantation,
and that DNMT3B specifically methylates a defined set of
CpG islands on autosomes and on the X chromosome.
This indicates that DNMT3 enzymes evolved to play both
redundant and specific functions in mammalian embryos.
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mechanisms responsible for the recruitment of DNMT3B
activity to CpG-dense regions, which might identify new
pathways inducing abnormal CGI methylation in cancer.
Materials and methods
Biological samples
All embryos were obtained from naturally mated C57BL/6
mice. We designated the morning of the vaginal plug as
E0.5 and performed all the dissections at the same hour of
the day (1 pm). Blastocysts (E3.5 to E4.5) were collected
by flushing the uteri with M2 medium. After implantation,
we manually dissected individual embryos in M2 medium.
At E5.5 to E7.5 we separated the epiblast from the extra-
embryonic tissues by manual dissection. We dissected
whole embryos at E8.5 to E10.5, and dissected forelimb
buds from E11.5 embryos. Sperm was isolated from the
caput epididymis of adult CD-1 mice. We prepared gen-
omic DNA by proteinase K digestion, phenol/chloroform
extraction and precipitation with ethanol. To generate
catalytically inactive mutants of Dnmt3 genes, we crossed
Dnmt3a-2lox [53] and Dnmt3b-2lox [54] mice (provided
by the Massachusetts General Hospital, Boston, MA, USA)
with a C57BL/6 ACTB-Cre deleter line [55] (provided by
the Institut Clinique de la Souris, Illkirch, France). Dnmt3
knockout embryos were then obtained by mating heterozy-
gous males and females.
Preparation of RRBS libraries
We prepared RRBS libraries from 100 pooled E3.5 blasto-
cysts, 50 pooled E4.5 blastocysts, 25 pooled E5.5 epiblasts,
15 pooled E6.5 epiblasts, and 10 pooled E7.5 epiblasts. At
E8.5, we prepared RRBS libraries from a pool of embryos
as well as two individual WT, Dnmt3a-/- and Dnmt3b-/-
embryos. At E10.5, we prepared RRBS libraries from pools
of WT embryos. At E11.5 we prepared RRBS libraries
from limbs of two WT and two Dnmt3b-/- embryos.
RRBS libraries were prepared according to a published
protocol [56] with modifications. Briefly, we digested 25 to
100 ng of genomic DNA for 5 h with MspI (Thermo Sci-
entific, Waltham, MA, USA) followed by end-repair, A-
tailing (with Klenow fragment, Thermo Scientific) and
ligation to paired-end methylated adapters (with T4 DNA
ligase, Thermo Scientific) in Tango 1X buffer. We purified
fragments in the range 150 to 400 bp (insert plus adapter
size) by electrophoresis on a 3% (w/v) agarose 0.5X TBE
gel with the MinElute gel extraction kit (Qiagen). We then
performed two rounds of bisulfite conversion with the
EpiTect kit (Qiagen) according to the manufacturer’s in-
structions. Final RRBS libraries were PCR amplified with
PfUTurbo Cx hotstart DNA polymerase (Agilent, Santa
Clara, CA, USA) and indexed PE Illumina primers using
the following PCR conditions: 95°C for 2 minutes, 14 to
16 cycles (95°C for 30 s, 65°C for 30 s, 72°C for 45 s),72°C for 7 minutes. The libraries were purified with AMPure
magnetic beads (Beckman Coulter, Brea, CA, USA), quanti-
fied with a Qubit fluorometer (Life Technologies, Carlsbad,
CA, USA) and verified by loading 10 ng of the library
on a 4-20% Criterion precast polyacrylamide gel (Biorad,
Hercules, CA, USA) stained with SYBR Green. The librar-
ies were paired-end sequenced (2 × 75 bp) in multiplex on
an Illumina HiSeq2000 by Integragen SA (Evry, France) to
generate an average of 30 million pairs of reads per sample
(Figure S1A in Additional file 1).
Processing of RRBS sequencing reads
We performed quality control checks on sequencing reads
with FastQC [57]. Reads were trimmed with Trim Galore
(v0.2.1) [58] to remove adapter sequences and low-quality
ends with a Phred score below 20. Trim Galore was run in
–rrbs mode to remove two additional bases artificially in-
troduced at the MspI restriction sites. We aligned sequen-
cing reads to the mouse mm10 genome with BSMAP
(v2.74) [59] using the RRBS mode. For the mapping, we
allowed a maximum of two mismatches and an insertion
size for paired-end sequences of between 30 and 400 bp.
We extracted methylation scores as the ratio of the
number of Cs over the total number of Cs and Ts. We
combined CpG methylation ratios from both strands and
filtered for a minimum sequencing depth of 8×. We esti-
mated the bisulfite conversion efficiency by calculating
the C to T conversion at non-CpG sites, which was in
most cases greater than 99.5% (Figure S1A in Additional
file 1). Methylation scores were visualized with the IGV
browser [60].
RRBS data analysis
RefSeq genes, transposons and CGI annotations were re-
trieved from the UCSC mm10 annotation. We filtered
transposons to have a minimum size of 200 bp. HCPs
(high CpG promoters), ICPs (intermediate CpG pro-
moters) and LCPs (low CpG promoters) were annotated
as previously described [19]. The genomic coordinates of
the imprinted DMRs were retrieved from the Wamidex
imprinting database [61]. The genomic coordinates of
canyons were retrieved from a published dataset [15].
For oocyte methylation, we retrieved a published RRBS
dataset (GSE34864) [6] and averaged the methylation
scores from all the oocyte replicates in the dataset. To
annotate CGIs, we measured the distance between the
middle of the CGI and the closest RefSeq TSS and over-
lapped CGIs with RefSeq exons and introns. We defined
the CGI categories as follows: TSS, the CGI is less than
1,000 bp from a TSS; exon, the CGI is more than 1,000 bp
from a TSS and overlaps at least 1 bp of an exon; intron,
the CGI is more than 1,000 bp from a TSS and is entirely
included in an intron; intergenic, the CGI does not meet
any of the previous criteria. To follow the global dynamics
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tiles containing at least three CpGs. To identify DNMT3B-
dependent targets, we selected genomic tiles with a differ-
ence in methylation (WT minus Dnmt3b-/-) greater than
60%, and then merged overlapping tiles. To analyze methy-
lation from single alleles, we mapped sequencing reads
with Bismark [62], which returns mapping information on
single reads. We then processed the Bismark output to ex-
tract methylation scores of individual sequenced mole-
cules. We performed gene ontology analysis using the
DAVID functional annotation tool [63]. All data processing
and representation were performed with the R software
using custom developed scripts.
Custom CGI annotation
To generate our custom CGI annotation, we split the
genome into 150 bp sliding windows with a 25 bp offset
and selected windows with a GC percentage greater than
55% and a CpG ratio (observed/expected) greater than
0.65. We then merged the windows closer than 50 bp
and selected the windows larger than 250 bp. To identify
high-confidence custom promoter CGIs (Additional file 3),
we used the same procedure with a minimal size of 225 bp,
and then filtered the custom CGIs to be less than 800 bp
from a RefSeq TSS.
Bisulfite sequencing and cloning
Bisulfite conversion of genomic DNA was performed with
the Epitect kit (Qiagen). We performed PCR amplifica-
tion of converted DNA followed by cloning as described
[7]. Cloned PCR products were sequenced, aligned with
the BISMA software [64] and filtered to remove clonal
biases. The sequences of the primers are provided in the
Additional file 6.
RNA-Seq
We prepared RNA-Seq libraries from three WT and
Dnmt3b-/- littermate embryos collected at E8.5. We ex-
tracted total RNAs from the embryos with the RNeasy
Protect Mini Kit (Qiagen) and verified the integrity of
RNAs with a Bioanalyzer (Agilent Technologies). RNA-
Seq libraries were prepared from 500 ng of total RNA by
Integragen SA using ribosomal RNA depletion with the
Ribo-Zero Gold kit (Epicentre, Madison, WI, USA) and
the TruSeq Stranded Total RNA Sample preparation kit
(Illumina), followed by paired-end sequencing (2 × 75bp)
on an Illumina HiSeq2000. The total numbers of paired-
end reads for each library are as follows: WT1, 73,493,661
pairs; WT2, 52,488,499 pairs; WT3, 64,138,495 pairs;
KO1, 61,632,013 pairs; KO2, 55,357,040 pairs; KO3,
60,179,105 pairs. We performed quality control checks
on sequencing reads with FastQC [57] and aligned reads
to the mouse mm10 genome with TopHat2 (v2.0.12)
[65]. For data visualization, we generated BigWig files ofnormalized read counts per base with bam2wig.py in the
RSeQC package (v2.4) [66] using only reads that map
uniquely in the genome. We calculated raw read counts in
mouse RefSeq exons from the BAM files with HTseq-
count (v0.6.0) [67] and used these counts to identify differ-
entially expressed genes with DESeq2 (v1.4.5) [68]. Genes
were called differentially expressed if the false discovery
rate-adjusted P-value between WT and knockout was
lower than 0.05 and the fold change greater than 2. Nor-
malized counts and Fragments Per Kilobase of exon per
Million fragments mapped (FPKM) scores were calculated
with the ‘counts’ and ‘fpkm’ functions of DESeq2.
RT-qPCR
RNAs were reverse transcribed with the Maxima first
strand cDNA synthesis kit (Thermo Scientific) using a
combination of oligo(dT) and random hexamer primers.
RT-qPCR was performed with the Fast SYBR Green
Master Mix (Life Technologies) on a StepOnePlus real-
time PCR system (Life Technologies). We used fast PCR
cycling conditions as follows: 95°C for 20 s, 40 cycles
(95°C for 20 s, 64°C for 30 s), followed by a dissociation
curve. We performed qPCR measurements in triplicate
reactions and normalized to the expression of two house-
keeping genes (Rpl13a, Actb). In parallel we systematically
amplified no-RT controls to rule out the presence of con-
taminating genomic DNA. Primer sequences for qPCR are
provided in Additional file 6.
Data access
The RRBS and RNA-Seq data have been deposited at the
NCBI Gene Expression Omnibus database [69] under
accession number GSE60334.Additional files
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